The Novartis Biome, whose first digital health innovation lab is based in San Francisco, has been co-founded by its head Mohanad Fors, head of open innovation Shwen Gwee and head of innovation and ...

The five-year deal to create a joint AI Innovation Lab, which will be reviewed every year, will initially focus on applying AI across Novartis’ internal processes. The aim is to create a data ...

Pathology is a field that seems ripe for assistance from recent advances in artificial intelligence. Beck’s company is one of ...

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...

North Carolina's life sciences ecosystem is thriving, thanks in no small part to the leadership and innovation of women ...

Why Google DeepMind, Perplexity, Khan Academy, Canva, and Salesforce are among Fast Company’s Most Innovative Companies for 2025.

After rising to prominence during the COVID-19 pandemic, South African drugmaker Aspen Pharmacare has landed in the FDA's ...

Industry veteran brings extensive oncology drug development expertise and experience in clinical treatment of cancer patients Dr. Matushansky ...

Industry veteran brings extensive oncology drug development expertise and experience in clinical treatment of cancer patients Dr. Matushansky joins as Immuneering plans to present updated data from Ph ...

To Novartis, fresh late-stage data support the idea that its intrathecal drug, which has the same active ingredient as ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...